These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 38661475)

  • 41. Efficacy of protamine zinc insulin for treatment of diabetes mellitus in cats.
    Nelson RW; Lynn RC; Wagner-Mann CC; Michels GM
    J Am Vet Med Assoc; 2001 Jan; 218(1):38-42. PubMed ID: 11149712
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Response to insulin treatment and survival in 104 cats with diabetes mellitus (1985-1995).
    Goossens MM; Nelson RW; Feldman EC; Griffey SM
    J Vet Intern Med; 1998; 12(1):1-6. PubMed ID: 9503353
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The Durability of Basal Insulin Affects Day-to-Day Glycemic Variability Assessed by Continuous Glucose Monitoring in Type 2 Diabetes Patients: A Randomized Crossover Trial.
    Iuchi H; Sakamoto M; Matsutani D; Suzuki H; Horiuchi R; Utsunomiya K
    Diabetes Technol Ther; 2017 Aug; 19(8):457-462. PubMed ID: 28605286
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Outcomes of glycemic control in type 1 diabetic patients switched from basal insulin glargine 100 U/ml to glargine 300 U/ml in real life.
    Oriot P; Jérémie W; Buysschaert M
    Expert Rev Endocrinol Metab; 2018 May; 13(3):167-171. PubMed ID: 30058899
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Glycaemic control and hypoglycaemia in people with type 2 diabetes switching from twice-daily basal insulin to once-daily insulin glargine 300 U/mL or insulin glargine 100 U/mL (EDITION 1 and EDITION 2 subgroup analysis).
    Roussel R; d'Emden MC; Fisher M; Ampudia-Blasco FJ; Stella P; Bizet F; Cali AMG; Wysham CH
    Diabetes Obes Metab; 2018 Feb; 20(2):448-452. PubMed ID: 28736942
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Home monitoring of the diabetic pet.
    Mathes MA
    Clin Tech Small Anim Pract; 2002 May; 17(2):86-95. PubMed ID: 12219722
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Pasireotide Long-Acting Release Treatment for Diabetic Cats with Underlying Hypersomatotropism.
    Gostelow R; Scudder C; Keyte S; Forcada Y; Fowkes RC; Schmid HA; Church DB; Niessen SJ
    J Vet Intern Med; 2017 Mar; 31(2):355-364. PubMed ID: 28145031
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Insulin Glargine 300 U/mL: A Review in Diabetes Mellitus.
    Blair HA; Keating GM
    Drugs; 2016 Mar; 76(3):363-74. PubMed ID: 26821280
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Loose-control of diabetes mellitus with protamine zinc insulin in cats: 185 cases (2005-2015).
    Restine LM; Norsworthy GD; Kass PH
    Can Vet J; 2019 Apr; 60(4):399-404. PubMed ID: 30992596
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Hypoglycaemia frequency and physiological response after double or triple doses of once-weekly insulin icodec vs once-daily insulin glargine U100 in type 2 diabetes: a randomised crossover trial.
    Pieber TR; Arfelt KN; Cailleteau R; Hart M; Kar S; Mursic I; Svehlikova E; Urschitz M; Haahr H
    Diabetologia; 2023 Aug; 66(8):1413-1430. PubMed ID: 37308751
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Insulin Glargine Dose and Weight Changes in Underweight, Normal Weight, and Overweight Children Newly Diagnosed with Type 1 Diabetes Mellitus.
    Chalk BS; Crane J; Yenokyan G; Pineda EM; Lee CKK
    Pharmacotherapy; 2019 Jul; 39(7):741-748. PubMed ID: 31102482
    [TBL] [Abstract][Full Text] [Related]  

  • 52. New insulin glargine 300 U/ml compared with glargine 100 U/ml in insulin-naïve people with type 2 diabetes on oral glucose-lowering drugs: a randomized controlled trial (EDITION 3).
    Bolli GB; Riddle MC; Bergenstal RM; Ziemen M; Sestakauskas K; Goyeau H; Home PD;
    Diabetes Obes Metab; 2015 Apr; 17(4):386-94. PubMed ID: 25641260
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Systematic review and economic evaluation of a long-acting insulin analogue, insulin glargine.
    Warren E; Weatherley-Jones E; Chilcott J; Beverley C
    Health Technol Assess; 2004 Nov; 8(45):iii, 1-57. PubMed ID: 15525480
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Comparisons of different measurements for monitoring diabetic cats treated with porcine insulin zinc suspension.
    Martin GJ; Rand JS
    Vet Rec; 2007 Jul; 161(2):52-8. PubMed ID: 17630418
    [TBL] [Abstract][Full Text] [Related]  

  • 55. One hundred years of insulin: Is it time for smart?
    Gilor C; Fleeman LM
    J Small Anim Pract; 2022 Sep; 63(9):645-660. PubMed ID: 35560042
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Insulin overdose in dogs and cats: 28 cases (1986-1993).
    Whitley NT; Drobatz KJ; Panciera DL
    J Am Vet Med Assoc; 1997 Aug; 211(3):326-30. PubMed ID: 9262672
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Long-term monitoring of the diabetic dog and cat. Clinical signs, serial blood glucose determinations, urine glucose, and glycated blood proteins.
    Miller E
    Vet Clin North Am Small Anim Pract; 1995 May; 25(3):571-84. PubMed ID: 7660533
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Owner experiences in treating dogs and cats diagnosed with diabetes mellitus in the United States.
    Aptekmann KP; Armstrong J; Coradini M; Rand J
    J Am Anim Hosp Assoc; 2014; 50(4):247-53. PubMed ID: 24855090
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A randomised, 52-week, treat-to-target trial comparing insulin detemir with insulin glargine when administered as add-on to glucose-lowering drugs in insulin-naive people with type 2 diabetes.
    Rosenstock J; Davies M; Home PD; Larsen J; Koenen C; Schernthaner G
    Diabetologia; 2008 Mar; 51(3):408-16. PubMed ID: 18204830
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A Randomized Trial of Insulin Glargine plus Oral Hypoglycemic Agents versus Continuous Subcutaneous Insulin Infusion to Treat Newly Diagnosed Type 2 Diabetes.
    Lin S; Chen M; Chen W; Lin K; Mu P; Zhu B; Xu W; Wang M; Weng J; Zeng L
    J Diabetes Res; 2018; 2018():2791584. PubMed ID: 30420969
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.